Back

Cardiovascular benefits of treatment with angiotensin receptor blockers in patients with hypertension and chronic kidney disease: a systematic review and meta-analysis

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hypertension treatment Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Michel Burnier

University of Lausanne, Lausanne (Switzerland)

5 More presentations in this session

Presentation thumbnail
New features of use of moxonidine as telomerase activator
Doctor E. Dudinskaya (Moscow, RU)
Abstract Slides
Presentation thumbnail
Renal artery branch denervation: evaluation of lesion characteristics using a thermochromic liquid crystal phantom model
Associate Professor P. Kovoor (Westmead, AU)
Abstract Slides
Presentation thumbnail
Regulation of cardiac ADAM-10 activity by sympathoadrenergic modulation and the role for RAGE-sRAGE balance and myocardial remodeling
Mrs O. Zamyatkin (Saarbruecken, DE)
Abstract
Presentation thumbnail
Calcium channel blocker monotherapy versus combination with renin-angiotensin system blockers in the development of new-onset diabetes mellitus in hypertensive Korean patients
Professor A. Her (Chuncheon, KR)
Abstract
Presentation thumbnail
Difference in renal parenchymal perfusion after renal denervation comparing treated vs. non-treated arteries
Mr R. Schmieder (Munich, DE)
Abstract

Access the full session

Session thumbnail
Hypertension treatment

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources